The role of adipokines in the improvement of diabetic and cardiovascular risk factors within a 52-week weight-loss programme for obesity.

CONCLUSION: In this study, Optifast52®, a multidisciplinary programme focusing on diet and lifestyle changes, was found not only to affect a decrease in parameters associated with diabetes and cardiovascular disease, but also to ameliorate in part the obesity-related imbalance of pro- and anti-inflammatory adipokines. PMID: 31591082 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31591082?dopt=Abstract

Source: Clin Med Res - October 3, 2019 Category: Research Authors: Hausmann J, Waechtershaeuser A, Behnken I, Aksan A, Blumenstein I, Brenner M, Loitsch SM, Stein J Tags: Obes Res Clin Pract Source Type: research